Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects
Abstract Background The aim was to improve upon an existing blood-based colorectal cancer (CRC) test directed to high-risk symptomatic patients, by developing a new CRC classifier to be used with a new test embodiment. The new test uses a robust assay format—electrochemiluminescence immunoassays—to...
Main Authors: | Lisa J. Croner, Roslyn Dillon, Athit Kao, Stefanie N. Kairs, Ryan Benz, Ib J. Christensen, Hans J. Nielsen, John E. Blume, Bruce Wilcox |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Clinical Proteomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12014-017-9163-z |
Similar Items
-
Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer
by: Armando Cevenini, et al.
Published: (2020-08-01) -
SSBP1 Upregulation In Colorectal Cancer Regulates Mitochondrial Mass
by: Yang Y, et al.
Published: (2019-12-01) -
Colorectal Cancer Study of Austria (CORSA): A Population-Based Multicenter Study
by: Andrea Gsur, et al.
Published: (2021-07-01) -
Cell Surface Markers in Colorectal Cancer Prognosis
by: Richard I. Christopherson, et al.
Published: (2010-12-01) -
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers
by: Maja Ludvigsen, et al.
Published: (2021-09-01)